Resolution of cutaneous old world and new world leishmaniasis after oral miltefosine treatment

American Journal of Tropical Medicine and Hygiene

Volumn 82, Issue 1, 2010, Pages 1-3

  Tappe, Dennis ^a,b   Müller, Andreas ^b   Stich, August ^b  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Medical Mission Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; GAMMA GLUTAMYLTRANSFERASE; MILTEFOSINE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CASE REPORT; DRUG EFFECT; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; LEISHMANIA BRAZILIENSIS; LEISHMANIA TROPICA; LIVER FUNCTION TEST; MALE; NAUSEA; NONHUMAN; POLYMERASE CHAIN REACTION; SIDE EFFECT; SKIN BIOPSY; SKIN DISEASE; SKIN LEISHMANIASIS; SKIN ULCER; THERAPY EFFECT; TRAVEL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ANTIPROTOZOAL AGENTS; FEMALE; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; PHOSPHORYLCHOLINE; TREATMENT OUTCOME;

EID: 74049099439     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.09-0490     Document Type: Article

References (2)

1. Berman JJ, 2008. Treatment of leishmaniasis with miltefosine: 2008 status. Expert Opin Drug Metab Toxicol 4: 1209-1216.
2. Sánchez-Cañete MP, Carvalho L, Pérez-Victoria FJ, Gamarro F, Castanys S, 2009. Low plasma membrane expression of the miltefosine transport complex renders Leishmania braziliensis refractory to the drug. Antimicrob Agents Chemother 53: 1305-1313.